home-hospital Hospital-level care for acutely ill adults in the comfort of their own home.
Learn more
home-hospital
Hospital-level care for acutely ill adults in the comfort of their own home. Learn more

Portfolio

Our Product Portfolio

Biovitals HF

BiovitalsHF®

Prescription software to enable early detection of heart failure exacerbation and augment guideline-directed use of heart failure medications.

Value proposition: • Reduces Length of Stay, 30-day rehospitalization rate and overall healthcare spending while improving quality of life and function in patients with heart failure

FDA 510(k) clearance for Biovitals® Analytics Engine and market authorization in the U.S. for BiovitalsHF® V1

Pipeline Rhythm

RhythmAnalytics®

Cloud-based Software for automated detection of over 15 types of cardiac arrhythmias

FDA 510(k) clearance for RhythmAnalytics® - A Software as a Service (SaaS) offering with scalable APIs to enable easy integration

Novel Deep Neural Network architecture trained on 4 Million EKGs to achieve highest degree of detection performance

Sentinel

Biovitals® Sentinel

Biovitals® Sentinel by Biofourmis allows for the continuous remote monitoring of critical biovitals and patient reported symptoms using Everion, an innovative new multi-sensor armband wearable.

Advanced AI/ML algorithms used to process the collected data and detect physiological change and predict events in various disease conditions, facilitating early intervention, and thereby dramatically improving outcomes of many traditional therapeutics.

Pain Focus

Painfocus™

Augments pain management by objective assessment of pain to guide personalized therapeutic decision-making

Proof-of-concept established in multiple pain types — cancer pain, post-orthopedic surgery

Two ongoing multi-center, clinical trials in post-operative pain and cancer pain

Gaido

Gaido™

Prescription Software to continuously monitor and detect early signs of deterioration in oncology patients, pre- and post- treatment

Gaido enables you to prevent avoidable readmissions and helps spare your patients from developing infections, sepsis, dehydration and other conditions

Value proposition: Reduce Length of stay, 30-days rehospitalization and overall healthcare spending while improving quality of life and function in patients with cancer

Biovitals Research

Biovitals® Research

Our modularized digital trial platform empowers patients and drives engagement while capturing real-time study data anytime, anywhere, from dynamic apps and connected devices

Our end-to-end platform provides a fully integrated suite of tools for digital clinical trials — remote passive monitoring using wearables, ePRO, eConsent, eCOA and eSource

Using our Biovitals® Analytics, we enable identification of novel patient-centric biomarkers as surrogate endpoints to achieve primary/secondary endpoints to speed up clinical trials

Digital therapeutics solutions for the real world

Our digital therapeutics portfolio consists of products that cover multiple therapeutic areas, including heart failure, acute coronary syndrome, COPD, oncology, and chronic pain.

See Life Sciences solutions
PRODUCT/CANDIDATE
THERAPEUTIC AREA
Research & Translation Pilot FDA Presub Pivotal FDA Authorization Commercial
PLATFORM
Biovitals® Analytics*

Disease Agnostic

Rhythm­Analytics®*

Cardiovascular

CARDIOMETABOLIC
Biovitals® V1

Heart Failure

Biovitals® V2 (BF110)

Heart Failure

BiovitalsCAD (BF111)

Coronary Artery Disease

BF112

Atrial Fibrillation / Obstructive Sleep Apnea

ONCOLOGY & PAIN
Gaido*

Solid Tumor

BF130

Solid Tumor

BF140

Pain

PLATFORM

RESEARCH & TRANSLATION PILOT FDA PRESUB PIVOTAL FDA AUTH. COMMERCIAL

Biovitals® Analytics*

Disease Agnostic

RhythmAnalytics®*

Cardiovascular

CARDIOMETABOLIC

BiovitalsHF® V1

Heart Failure

BiovitalsHF® V2 (BF110)

Heart Failure

BiovitalsCAD (BF111)

CAD

BFF112

AF/OSA

ONCOLOGY & PAIN

Gaido*

Solid Tumor

BF130

Solid Tumor

BF140

Pain

Internal product candidates

Partnered/In-licensing product candidates

**Products have also obtained regulatory approval in countries outside the U.S.

Contact Us